Interleukin-5 and the regulation of eosinophil production

Current Opinion in Hematology

Volumn 6, Issue 3, 1999, Pages 164-168

  Roboz, Gail J ^a   Rafii, Shahin ^a  

^a Joan/Standford I W M C of C U   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 5;

ADOPTIVE TRANSFER; ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CELL STIMULATION; EOSINOPHIL; IMMUNE RESPONSE; INFLAMMATORY CELL; MOLECULAR CLONING; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; EOSINOPHILS; HEMATOPOIESIS; HUMANS; INTERLEUKIN-5; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 0032885128     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199905000-00007     Document Type: Article

References (44)

1. 1 Boyce JA, Friend D, Matsumoto R, Austen KF, Owen WF: Differentiation in vitro of hybrid eosinophil/basophil granulocytes: autocrine function of an eosinophil developmental intermediate. J Exp Med 1995, 182:49-57.
2. 2 Clutterbuck EJ, Hirst EM, Sanderson CJ: Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6 and GM-CSF. Blood 1989, 73:1504-1512.
3. 3 Rothenberg ME: Eosinophilia. N Engl J Med 1998, 338:1592-1600. This paper presents an excellent, concise review.
4. 4 Adachi T, Alam R: The mechanism of IL-5 signal transduction. Am J Physiol 1998, 275:623-633. This paper presents a detailed review of this subject.
5. 5 Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG: Interleukin-5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996, 183:195-201.
6. 6 Hokibara S, Takamoto M, Tominaga A, Takatsu K, Sugane K: Marked eosinophilia in interleukin-5 transgenic mice fails to prevent Trichinella spiralis infection. J Parasitol 1997, 83:1186-1189.
7. 7 Hiraguri M, Miike S, Sano H, Kurasawa K, Saito Y, Iwamoto I: Granulocyte-macrophage colony-stimulating factor and IL-5 activate mitogen-activated protein kinase through Jak2 kinase and phosphatidylinositol 3-kinase in human eosinophils. J Allergy Clin Immunol 1997, 100(suppl):S45-S51.
8. 8 Kato M, Kita H, Tokuyama K, Morikawa A: Signal transduction in activation of human eosinophils: G protein-dependent and independent pathways. Int Arch Allergy Immunol 1998, 117:63-67.
9. 9 Ogata N, Kouro T, Yamada A, Koike M, Hanai N, Ishikawa T, Takatsu K: JAK2 and JAK1 constitutively associate with an interleukin-5 (IL-5) receptor alpha and beta subunit, respectively, and are activated upon IL-5 stimulation. Blood 1998, 91:2264-2271.
10. 10 Bates ME, Busse WW, Bertics PJ: Interleukin-5 signals through Shc and Grb2 in human eosinophils. Am J Respir Cell Mol Biol 1998, 18:75-83.
11. 11 van der Bruggen T, Kanters D, Tool AT, Raaijmakers JA, Lammers JW, Verhoeven AJ, Koenderman L: Cytokine-induced protein tyrosine phosphorylation is essential for cytokine priming of human eosinophils. J Allergy Clin Immunol 1998, 101:103-109.
12. 12 Coffer PJ, Schweitzer RC, Dubois GR, Maikoe T, Lammers JW, Koenderman L: Analysis of signal transduction pathways in human eosinophils activated by chemoattractants and the T-helper 2-derived cytokines interleukin-4 and interleukin-5. Blood 1998, 91:2547-2557.
13. 13 Pazdrak K, Olszewska-Pazdrak B, Stafford S, Garofalo RP, Alam R: Lyn, Jak2 and Raf-1 kinases are critical for the antiapoptotic effect of interleukin-5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation. J Exp Med 1998, 188:421-429. This important papers identifies specific signaling molecules responsible for certain eosinophil functions.
14. 14 Fujisawa T, Terada A, Atsuta J, Iguchi K, Kamiya H, Sakurai M: IL-5 as a strong secretagogue for human eosinophils. Int Arch Allergy Immunol 1997, 114:81-83.
15. 15 Kato M, Abraham RT, Okada S, Kita H: Ligation of the beta2 integrin triggers activation and degranulation of human eosinophils. Am J Respir Cell Mol Biol 1998, 18:657-686.
16. 16 Kato M, Kita H, Tokuyama K, Morikawa A: Cross-linking of the beta2 integrin, CD11b/CD18, on human eosinophils induces protein tyrosine phosphorylation and cellular degranulation. Int Arch Allergy Immunol 1998, 117:68-71.
17. 17 Walsh GM: Human eosinophils: their accumulation, activation and fate. Br J Haematol 1997, 97:701-709.
18. 18 Dibbert B, Daigle I, Braun D, Schranz C, Weber M, Blaser K, et al.: Role for Bcl-xL in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5. Blood 1998, 92:778-783.
19. 19 Luttmann W, Opfer A, Dauer E, Foerster M, Matthys H, Eibel H, et al.: Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils. Eur J Immunol 1998, 26:2057-2065.
20. 20 Takatsu K, Takaki S, Hitoshi Y: Interleukin-5 and its receptor system: implications in the immune system and inflammation. Adv Immunol 1994, 57:145-190.
21. 21 Samoszuk M, Nansen L: Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 1990, 75:13-16.
22. 22 Paul CC, Keller JR, Armpriester JM, Baumann MA: Epstein-Barr virus transformed B lymphocytes produce interleukin-5. Blood 1990, 75:1400-1403.
23. 23 Walker C, Checkel J, Cammisuli S, Leibson PJ, Gleich GJ: IL-5 production by NK cells contributes to eosinophil infiltration in a mouse model of allergic inflammation. J Immunol 1998, 161:1962-1969.
24. 24 Minshall EM, Schleimer R, Cameron L, Minnicozzi M, Egan RW, Gutierrez-Ramos JC, et al.: Interleukin-5 expression in the bone marrow of sensitized Balb/c mice after allergen challenge. Am J Respir Crit Care Med 1998, 158:951-957.
25. 25 Mohle R, Salemi P, Moore MAS, Rafii S: Expression of interleukin-5 by human bone marrow microvascular endothelial cells: implications for the regulation of eosinophilopoiesis in vivo. Br J Haematol 1997, 99:732-738. The work presented in this paper demonstrates IL-5 expression by bone marrow microvascular endothelial cells.
26. 26 Rafii S, Shapiro F, Rimarachin J, Nachman RL, Ferris B, Weksler B, et al.: Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion. Blood 1994, 84:10-19.
27. 27 Rafii S, Candal FJ, Shapiro F, Mohle R, Querijero M, Greenberg E, et al.: Immortalized human bone marrow endothelial cells (BMEC-1) support long-term multilineage hemopoiesis [abstract]. Blood 1995, 86(suppl 1):495a.
28. 28 Rafii S, Shapiro F, Pettengell R, Ferris B, Nachman RL, Moore MAS, Asch A: Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood 1995, 86:3353-3363.
29. 29 Griffiths-Johnson DA, Collins PD, Rossi AG, Jose PJ, Williams TJ: The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem Biophys Res Commun 1993, 197:1167-1172.
30. 30 Humbles AA, Conroy DM, Marleau S, Rankin SM, Palframan RT, Proudfoot AE, et al.: Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med 1997, 186:601-612.
31. 31 Collins PD, Marloau S, Griffiths-Johnson DA, Jose PJ, Williams TJ: Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995, 182:1169-1174.
32. 32 Palframan RT, Collins PD, Williams TJ, Rankin SM: Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 1998, 91:2240-2248. The work presented in this paper supports a role for the chemokine eotaxin in eosinophil mobilization.
33. 33 Mould AW, Matthaei KI, Young IG, Foster PS: Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J Clin Invest 1997, 99:1064-1071.
34. 34 Palframan RT, Collins PD, Severs NJ, Rothery S, Williams TJ, Rankin S: Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin-5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase. J Exp Med 1998, 188:1621-1632. This particularly interesting paper explores mechanisms of mobilization of eosinophils from the bone marrow.
35. 35 Yuan Q, Austen KF, Friend DS, Heidtman M, Boyce JA: Human peripheral blood eosinophils express a functional c-kit receptor for stem cell factor that stimulates very late antigen 4 (VLA-4)-mediated cell adhesion to fibronectin and vascular cell adhesion molecule 1 (VCAM-1). J Exp Med 1997, 186:313-323.
36. 36 Sanderson CJ: Interleukin-5, eosinophils and disease. Blood 1992, 79:3101-3109.
37. 37 Masuyama K, Till SJ, Jacobson MR, Kamil A, Cameron L, Juliusson S, et al.: Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids. J Allergy Clin Immunol 1998, 102:610-617.
38. 38 Hamilos DL, Leung DY, Huston DP, Kamil A, Wood R, Hamid Q: GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis. Clin Exp Allergy 1998, 28:1145-1152.
39. 39 Hingorani M, Calder V, Jolly G, Buckley RJ, Lightman SL: Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases. J Allergy Clin Immunol 1998, 102:821-830.
40. 40 Pinto A, Aldinucci D, Gloghini A, Zagonel V, Degan M, Perin V, et al.: The role of eosinophils in the pathobiology of Hodgkin's disease. Ann Oncol 1997, 8(suppl):S89-S96.
41. 41 Monahan J, Siegel N, Keith R, Caparon M, Christine L, Compton R, et al.: Attenuation of IL-5-mediated signal transduction, eosinophil survival, and inflammatory mediator release by a soluble human IL-5 receptor. J Immunol 1997, 159:4024-4034.
42. 42 Motojima S, Tateishi K, Koseki T, Makino S, Fukuda T: Serum levels of eosinophil cationic protein and IL-5 in patients with asthma without systemic corticosteroids. Int Arch Allergy Immunol 1997, 114(suppl 1):55-59.
43. 43 Okada S, Hagan JB, Kato M, Bankers-Fulbright JL, Hunt LW, Gleich GJ, Kita H: Lidocaine and its analogues inhibit IL-5-mediated survival and activation of human eosinophils. J Immunol 1998, 160:4010-4017.
44. 44 Weltman JK, Karim AS: Interleukin-5: a proeosinophil cytokine mediator of inflammation in asthma and a target for antisense therapy. Allergy Asthma Proc 1998, 19:257-262.